Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A standard fluoride-containing toothpaste, specifically Colgate Cavity Protection, utilized as the control arm in a Phase 3 clinical trial (NCT02535312) sponsored by Tufts University. The trial evaluates changes in the oral environment of adult patients suffering from medication-induced xerostomia (dry mouth). This control formulation contains 1000 ppm fluoride (typically as sodium fluoride), which serves as the active comparator against an investigative 8% arginine-containing toothpaste. Fluoride is a well-established pharmaceutical agent for the prevention of dental caries; it works by promoting the remineralization of tooth enamel and inhibiting the metabolic activity of acid-producing oral bacteria. In the context of the Tufts study, it was used to establish a baseline for oral health parameters in patients taking multiple xerostogenic medications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1000 ppm fluoride toothpaste.